| Primary Central Nervous System Neoplasm investigated in trials for …INVESTIGATED_IN_TRIALSderived200 of 236show all (up to 200) |
|---|
| → investigated in trials for | Temozolomidesmall molecule 387 trials (122 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 387 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 148 trials (26 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 148 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 59 trials (27 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 59 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 51 trials (26 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 51 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lomustinesmall molecule 50 trials (15 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 50 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 43 trials (14 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 43 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 43 trials (18 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 43 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 35 trials (7 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 35 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Methotrexatesmall molecule 30 trials (12 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 30 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 29 trials (11 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 29 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 25 trials (11 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 25 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rituximabmonoclonal antibody 24 trials (11 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall molecule 23 trials (5 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vincristinesmall molecule 23 trials (11 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vorinostatsmall molecule 21 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 17 trials (8 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenalidomidesmall molecule 17 trials (6 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Topotecansmall molecule 17 trials (4 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carmustinesmall molecule 15 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunitinibsmall molecule 15 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 14 trials (6 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 14 trials (6 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dordavipronesmall molecule 13 trials (3 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Filgrastimother 13 trials (4 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ibrutinibsmall molecule 13 trials (8 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temsirolimussmall molecule 13 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abemaciclibsmall molecule 12 trials (6 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 12 trials (8 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | 5-Aminolevulinic Acid 11 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cediranibsmall molecule 11 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dasatinibsmall molecule 11 trials (3 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Olaparibsmall molecule 11 trials (8 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selumetinibsmall molecule 11 trials (7 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trametinibsmall molecule 11 trials (8 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 10 trials (5 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Palbociclibsmall molecule 10 trials (4 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tipifarnibsmall molecule 10 trials (2 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vismodegibsmall molecule 10 trials (3 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinibsmall molecule 9 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 9 trials (3 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Metforminsmall molecule 9 trials (5 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Niraparibsmall molecule 9 trials (5 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panobinostatsmall molecule 9 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tovorafenibsmall molecule 9 trials (6 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vorasidenibsmall molecule 9 trials (6 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bortezomibsmall molecule 8 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabozantinibsmall molecule 8 trials (3 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 8 trials (4 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Melphalansmall molecule 8 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Retifanlimabmonoclonal antibody 8 trials (7 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ribociclibsmall molecule 8 trials (2 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall molecule 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cemiplimabmonoclonal antibody 7 trials (4 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dabrafenibsmall molecule 7 trials (6 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinib Hydrochloridesmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pazopanibsmall molecule 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selinexorsmall molecule 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sonidegibsmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thiotepasmall molecule 7 trials (2 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Valproic Acidsmall molecule 7 trials (2 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aminolevulinic Acidsmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avelumabmonoclonal antibody 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enzastaurinsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hydroxyureasmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ifosfamidesmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinib Mesylatesmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imiquimodsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall molecule 6 trials (4 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemetrexedsmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pomalidomidesmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Regorafenibsmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adavosertibsmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Azacitidinesmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Binimetinibsmall molecule 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Buparlisibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Celecoxibsmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cetuximabmonoclonal antibody 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gefitinibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Safusidenibsmall molecule 5 trials (4 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenib Tosylatesmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tazemetostatsmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thalidomidesmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vandetanibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Veliparibsmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinblastinesmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afatinibsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Axitinibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Busulfansmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chloroquinesmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erdafitinibsmall molecule 4 trials (4 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fluorouracilsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ivosidenibsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lapatinibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Larotrectinibsmall molecule 4 trials (4 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenvatinibsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lutetium (177lu) Oxodotreotideother 4 trials (4 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nimotuzumabmonoclonal antibody 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | O6-Benzylguaninesmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Obinutuzumabmonoclonal antibody 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegargiminaseother 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegfilgrastimother 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Plerixaforsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sintilimabmonoclonal antibody 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sirolimussmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tarlatamabmonoclonal antibody 4 trials (4 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vemurafenibsmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zanubrutinibsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bimiralisibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cobimetinibsmall molecule 3 trials (3 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Crenolanibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Crizotinibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cytarabinesmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Infigratinibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mirdametinibsmall molecule 3 trials (3 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nintedanibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Procarbazinesmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Romidepsinother 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sacituzumab Govitecanadc 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sapanisertibsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tamoxifensmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Therapeutic Tumor Infiltrating Lymphocytes 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinorelbinesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vistusertibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Acalabrutinibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afliberceptother 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Akt Inhibitor MK2206 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alisertibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bosutinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Camrelizumabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capivasertibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capmatinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ceritinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cixutumumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Claturafenibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Copanlisibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dovitinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ensartinibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Entrectinibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Epcoritamabmonoclonal antibody 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | FACT Complex-targeting Curaxin CBL0137 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipatasertibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mercaptopurinesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Navtemadlinsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Neratinibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Osimertinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pan-RAF/MEK Molecular Glue NST-628 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Peginterferon Alfa-2bother 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Perifosinesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pexidartinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisonesmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prexasertibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ruxolitinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Samotolisibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selpercatinibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Serplulimabmonoclonal antibody 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tremelimumabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vatalanibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Venetoclaxsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abexinostatsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adebrelimabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adjuvant Chemotherapy 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alectinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alpelisibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alvocidibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Amivantamabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Arsenic Trioxidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aspirinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bafetinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belinostatsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belzutifansmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bendamustinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bicalutamidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Birabresibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Brigatinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabazitaxelsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dabrafenib/Trametinib Regimen 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dacomitinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Daratumumabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dostarlimabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enasidenibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Encorafenibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fexagratinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Futuximab/Modotuximab Mixture 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Glasdegibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Glofitamabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | HDAC Inhibitor REC-2282 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hydroxychloroquinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumab/Nivolumab Regimen 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ixazomibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lonafarnibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lorlatinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lurbinectedinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Neoplasm | 1 | Observed | clinicaltrials | graph → |